{
    "code": "56033666",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56033666",
    "time": "2021-02-19 05:04:10",
    "許可證字號": "衛部醫器輸字第033666號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD11686",
    "有效日期": "114\/07\/22",
    "發證日期": "109\/07\/22",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA05603366601",
    "中文品名": "“瓦里歐”氮化矽植骨頸椎椎間融合器",
    "英文品名": "“Valeo” C+CSC Cervical Interbody Fusion Device",
    "效能": "“瓦里歐”氮化矽植骨頸椎椎間融合器適用於骨骼成熟且需要執行脊椎椎間融合手術的病人。“瓦里歐”氮化矽植骨頸椎椎間融合器適用於治療C3-T1之間單節段的頸椎椎間盤病變。退化性椎間盤病變被定義為椎間盤源性疼痛，經病史和影像學檢查證實為椎間盤退變。退化性椎間盤病變患者也可能在所涉及的節段上合併有I級脊椎滑脫症。“瓦里歐”氮化矽植骨頸椎椎間融合器適用於病患已做過非手術治療達六週以上。",
    "醫器規格": "詳如中文仿單核定本",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "N骨科用裝置",
    "醫器次類別一": "N3080椎體間融合裝置",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "623106L177  席緹歐股份有限公司",
    "申請商地址": "新北市新莊區新北大道4段179號(1樓)",
    "主製造廠": [
        {
            "製造廠名稱": "MUS5471000  CTL MEDICAL CORPORATION",
            "製造廠廠址": "4550 EXCEL PARKWAY SUITE 300 ADDISON, TX 75001, U. S. A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560336660001-109-08-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56033666&Seq=001&Type=9"
        },
        {
            "title": "560336660002-109-08-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56033666&Seq=001&Type=8"
        }
    ]
}